<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>VEGF is a secreted <z:chebi fb="0" ids="52290">mitogen</z:chebi> associated with <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and is also a potent vascular permeability factor </plain></SENT>
<SENT sid="1" pm="."><plain>The biological role of VEGF in the ischemic brain remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>This study was undertaken to investigate whether VEGF enhances cerebral microvascular perfusion and increases blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) leakage in the ischemic brain </plain></SENT>
<SENT sid="3" pm="."><plain>Using magnetic resonance imaging (MRI), three-dimensional laser-scanning confocal microscope, and functional neurological tests, we measured the effects of administrating recombinant human VEGF(165) (rhVEGF(165)) on <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, functional neurological outcome, and <z:chebi fb="2" ids="33602">BBB</z:chebi> leakage in a rat model of focal cerebral embolic <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Late (48 hours) administration of rhVEGF(165) to the ischemic rats <z:mp ids='MP_0005601'>enhanced angiogenesis</z:mp> in the ischemic penumbra and significantly improved neurological recovery </plain></SENT>
<SENT sid="5" pm="."><plain>However, early postischemic (1 hour) administration of rhVEGF(165) to ischemic rats significantly increased <z:chebi fb="2" ids="33602">BBB</z:chebi> leakage, hemorrhagic transformation, and ischemic lesions </plain></SENT>
<SENT sid="6" pm="."><plain>Administration of rhVEGF(165) to ischemic rats did not change <z:chebi fb="2" ids="33602">BBB</z:chebi> leakage and cerebral plasma perfusion in the contralateral hemisphere </plain></SENT>
<SENT sid="7" pm="."><plain>Our results indicate that VEGF can markedly enhance <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in the ischemic brain and reduce neurological deficits during <z:hpo ids='HP_0001297'>stroke</z:hpo> recovery and that inhibition of VEGF at the <z:hpo ids='HP_0011009'>acute</z:hpo> stage of <z:hpo ids='HP_0001297'>stroke</z:hpo> may reduce the <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability and the risk of hemorrhagic transformation after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>